首页 | 官方网站   微博 | 高级检索  
     

多西紫杉醇联合化疗法治疗非小细胞肺癌的研究进展
引用本文:赵淑芳,王立升.多西紫杉醇联合化疗法治疗非小细胞肺癌的研究进展[J].中国现代应用药学,2012,29(2):117-121.
作者姓名:赵淑芳  王立升
作者单位:广西大学化学化工学院,南宁 530004
基金项目:广西自然科学基金重点项目(2010GXNSFD013040)
摘    要:目的介绍多西紫杉醇联合化疗法治疗非小细胞肺癌的研究进展。方法通过查阅国内外的文献资料,讨论多西紫杉醇联合铂类制剂和非铂类第3代药物的临床疗效和不良反应。结果多西紫杉醇联合化疗法治疗非小细胞肺癌疗效确切、不良反应轻微。结论联合化疗方案有望解决单药方案有效率略低的问题,并为非小细胞肺癌的治疗提供临床指导。

关 键 词:非小细胞肺癌  多西紫杉醇  联合治疗
收稿时间:7/1/2011 12:00:00 AM
修稿时间:2011/11/11 0:00:00

Progress of Docetaxel Combining with Chemotherapy in Treatment of Non-small Cell Lung Cancer
ZHAO Shufang,WANG Lisheng.Progress of Docetaxel Combining with Chemotherapy in Treatment of Non-small Cell Lung Cancer[J].The Chinese Journal of Modern Applied Pharmacy,2012,29(2):117-121.
Authors:ZHAO Shufang  WANG Lisheng
Affiliation:School of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China
Abstract:OBJECTIVE To introduce the progress of the combined treatment of docetaxel and chemotherapy for non-small cell lung cancer. METHODS By investigating the national and international literatures, the clinical effects and adverse reactions of docetaxel combining with platinum agents and non-platinum drugs were discussed. RESULTS The efficacy was definite and adverse effects were light in treatment of non-small cell lung cancer by docetaxel combining with chemotherapy. CONCLUSION The combined therapy is expected to solve the single-agent problem of low effects and provide the clinical guidance.
Keywords:non-small cell lung cancer  docetaxel  combination therapy
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号